Literature DB >> 21392830

Metabolic syndrome and insulin resistance are associated with abnormal left ventricular diastolic function and structure independent of blood pressure and fasting plasma glucose level.

You-Cheol Hwang1, Jae Hwan Jee, Mira Kang, Eun-Jung Rhee, Jidong Sung, Moon-Kyu Lee.   

Abstract

BACKGROUND: Abnormal left ventricular (LV) structure and diastolic function are frequently detected in a variety of heart diseases, and insulin resistance has been suggested to be associated with LV diastolic dysfunction (LVDD). The aims of this study were to determine the association between LVDD or LV structure and metabolic syndrome (MetS) or insulin resistance, and whether or not the associations are independent of age, blood pressure, and plasma glucose level.
METHODS: A total of 1599 subjects (1161 men and 398 women), 25-83 years of age, who underwent medical health check-ups at two institutions, were enrolled. LV diastolic function and structure were assessed by echocardiographic evaluation, including tissue Doppler imaging (TDI).
RESULTS: The subjects with MetS had significant differences in the level of parameters reflecting cardiac structure and LV diastolic function compared to those without MetS, even after adjustment for age, gender, blood pressure, and fasting plasma glucose level (P<0.001). MetS was independently associated with an increased risk for LVDD (OR, 1.67; 95% CI, 1.18-2.37; P = 0.004). In addition, as the HOMA-IR value increased, the level of parameters reflecting cardiac structure and LVDD significantly increased and the E/A ratio significantly decreased (P<0.001). Furthermore, the LV mass, E/A ratio, and E/E' ratio were significantly different across the HOMA-IR quartiles, even after adjustment for other confounders.
CONCLUSIONS: MetS and insulin resistance are associated with abnormal LV diastolic function and structure independent of age, gender, blood pressure, and fasting plasma glucose level.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392830     DOI: 10.1016/j.ijcard.2011.02.039

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  24 in total

1.  Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals.

Authors:  Yi-Chih Wang; Chang-Seng Liang; Deepa M Gopal; Nir Ayalon; Courtney Donohue; Rajalakshmi Santhanakrishnan; Harpaul Sandhu; Alejandro J Perez; Jill Downing; Noyan Gokce; Wilson S Colucci; Jennifer E Ho
Journal:  Circ Heart Fail       Date:  2015-07-14       Impact factor: 8.790

Review 2.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

Review 3.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 4.  Role of autophagy in metabolic syndrome-associated heart disease.

Authors:  Sidney Y Ren; Xihui Xu
Journal:  Biochim Biophys Acta       Date:  2014-05-05

5.  Bone mineral density is associated with left ventricular diastolic function in women.

Authors:  Rui-Tao Wang; Xue-Song Li; Ji-Rong Zhang; Yuxiang Sun; Kai-Jiang Yu; Tiemin Liu
Journal:  Clin Cardiol       Date:  2016-10-07       Impact factor: 2.882

Review 6.  Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.

Authors:  Bernd Niemann; Susanne Rohrbach; Mark R Miller; David E Newby; Valentin Fuster; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

7.  Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure.

Authors:  Hoyoun Won; Seok-Min Kang; Min-Jeong Shin; Jaewon Oh; Namki Hong; Sungha Park; Sang-Hak Lee; Yangsoo Jang; Namsik Chung
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

8.  Central versus peripheral cardiovascular risk in metabolic syndrome.

Authors:  H Edgell; R J Petrella; G J Hodges; J K Shoemaker
Journal:  Front Physiol       Date:  2012-02-27       Impact factor: 4.566

9.  Association between metabolic syndrome and left ventricular geometric change including diastolic dysfunction.

Authors:  Seung-Jae Lee; Hyunah Kim; Byeong Kil Oh; Hyo-In Choi; Ki-Chul Sung; Jeonggyu Kang; Mi Yeon Lee; Jong-Young Lee
Journal:  Clin Cardiol       Date:  2022-05-03       Impact factor: 3.287

10.  Association between Low-Grade Inflammation and Left Ventricular Diastolic Dysfunction in Patients with Metabolic Syndrome and Hyperuricemia.

Authors:  Cheng-Wei Liu; Jui-Hung Chen; Guo-Shiang Tseng; Ko-Hung Chen; Juey-Jen Hwang; Wei-Shiung Yang; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.